Clinical Trials
All Clinical Trials - Page 43 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03018314N/ACompleted
Serum Kisspeptin Levels in Infertile Women
Kisspeptin
- NCT02974270Phase 4Unknown
Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
Gonadorelin
- NCT02716974Phase 2Completed
A Study of Definitive Therapy to Treat Prostate Cancer
Gonadorelin
- NCT02592746Phase 2Unknown
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
Gonadorelin
- NCT02535299Phase 4Unknown
Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
Liraglutide
- NCT02718950Phase 3Unknown
Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
Liraglutide
- NCT02811484Phase 4Withdrawn
Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
Exenatide
- NCT02788578N/ATerminated
A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours
Lanreotide
- NCT02781493Phase 4Unknown
Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy
Linaclotide
- NCT02773368Phase 3Completed
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT02752828Phase 3Completed
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Lixisenatide
- NCT03703778N/AActive Not Recruiting
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)
Gonadorelin
- NCT02686177Phase 4Completed
Effect of GLP-1 on Angiogenesis
Liraglutide
- NCT02752412Phase 3Completed
Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
Lixisenatide
- NCT02773355N/ACompleted
Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients
Liraglutide
- NCT02759107Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
Tirzepatide
- NCT02749890Phase 3Completed
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Lixisenatide
- NCT02787447Phase 2Unknown
Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI Therapy
Thymosin-Alpha-1
- NCT03426085Phase 2Unknown
The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
Liraglutide
- NCT02488057Phase 4Completed
Improving Beta Cell Function in Mexican American Women With Prediabetes
Liraglutide
- NCT02736448Phase 2Terminated
177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors
Octreotide
- NCT02754817N/ACompleted
A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus
Liraglutide
- NCT02663908Phase 3Terminated
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Gonadorelin
- NCT02690883Phase 4Completed
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
Exenatide
- NCT03182192Phase 1Unknown
GLP1R-imaging in Hypoglycemia
Exenatide
- NCT04112875N/ACompleted
Effect of L-arginine on Microcirculation, Myogenesis and Angiogenesis Associated With Aging, Sarcopenia and Diabetes
Follistatin
- NCT02737800N/ACompleted
Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients
Gonadorelin
- NCT02713477Phase 1Completed
Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus
Lixisenatide
- NCT02823691EARLY_Phase 1Unknown
The MetNET-2 Trial
Lanreotide
- NCT02883595Phase 4Completed
Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis
Thymosin-Alpha-1
- NCT02635386Phase 3Completed
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Exenatide
- NCT03209518N/ACompleted
Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"
Gonadorelin
- NCT02717858Phase 1Completed
A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
Liraglutide
- NCT02696148Phase 1Completed
A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
Liraglutide
- NCT02677896Phase 3Completed
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Gonadorelin
- NCT02655237Phase 3Completed
A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids
Gonadorelin
- NCT02777073N/ACompleted
Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
Liraglutide
- NCT02693119Phase 2Completed
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy
Elamipretide
- NCT02606500Phase 4Completed
Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success
Gonadorelin
- NCT02703584Phase 4Completed
Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation
Gonadorelin
- NCT02532400Phase 3Terminated
Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients
Gonadorelin
- NCT02736032Phase 3Completed
Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist
Gonadorelin
- NCT02908087Phase 2Completed
Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
Liraglutide
- NCT02898506Phase 2Completed
Incretin-based Therapy in Late Preclinical Type 1 Diabetes
Liraglutide
- NCT02770885Phase 2Completed
Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
Dulaglutide
- NCT02664441Phase 3Completed
Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
Exenatide
- NCT02404376Phase 3Completed
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
Exenatide
- NCT02729766Phase 2/Phase 3Completed
Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study
Desmopressin
- NCT03342287N/AWithdrawn
Cognitive and Psychiatric Effects of Linaclotide on Patients With Constipation
Linaclotide
- NCT04140409Phase 4Terminated
Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation
Octreotide